Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Mycoses 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Neutropenia 1Myelodysplastic Syndromes 1Leukemia 1Invasive Fungal Infections 1Glioblastoma 1Bronchiolitis Obliterans Syndrome 1Brain Neoplasms 1Bone Marrow Neoplasms 1

Interventions

pegfilgrastim 9Filgrastim 6eflapegrastim 3Docetaxel 3Cyclophosphamide 3posaconazole 1plerixafor 1isavuconazole 1ceftobiprole medocaril 1angiotensin I (1-7) 1Vancomycin 1Sodium Chloride 1N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 1Levofloxacin 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1EC regimen 1Daptomycin 1Cefepime 1Caspofungin 1Bevacizumab 1Algorithms 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neutropenia × posaconazole × Clear all
NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Merck Sharp & Dohme LLC

Phase 4 Completed
75 enrolled 14 charts
Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡